Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

This study is currently recruiting participants.
Verified January 2014 by H. Lee Moffitt Cancer Center and Research Institute
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT01373294
First received: June 13, 2011
Last updated: January 7, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)